US4783443A
(en)
|
1986-03-03 |
1988-11-08 |
The University Of Chicago |
Amino acyl cephalosporin derivatives
|
US5844092A
(en)
|
1994-03-18 |
1998-12-01 |
Genentech, Inc. |
Human TRK receptors and neurotrophic factor inhibitors
|
US5877016A
(en)
|
1994-03-18 |
1999-03-02 |
Genentech, Inc. |
Human trk receptors and neurotrophic factor inhibitors
|
ATE335003T1
(de)
|
1996-05-08 |
2006-08-15 |
Biogen Idec Inc |
Ret-ligand 3 (retl3), um neurales und renales wachstum zu stimulieren
|
US6677135B1
(en)
|
1996-05-08 |
2004-01-13 |
Biogen, Inc. |
Ret ligand (RetL) for stimulating neutral and renal growth
|
US6682921B1
(en)
|
1996-08-21 |
2004-01-27 |
New York University |
Crystals of the tyrosine kinase domain of non-insulin receptor tyrosine kinases
|
US6531152B1
(en)
|
1998-09-30 |
2003-03-11 |
Dexcel Pharma Technologies Ltd. |
Immediate release gastrointestinal drug delivery system
|
WO2001016169A2
(en)
|
1999-09-01 |
2001-03-08 |
Biogen, Inc. |
RET LIGAND 5 (Retl5) FROM HUMAN AND MOUSE
|
FI20000403A0
(fi)
|
2000-02-22 |
2000-02-22 |
Hannu Sariola |
GDNF perhesukuisten yhdisteiden käyttö kivessyövän hoitoon tarkoitettujen tuotteiden valmistamiseksi
|
AU2001271422B2
(en)
|
2000-06-22 |
2005-12-22 |
Genentech, Inc. |
Agonist anti-trk-C monoclonal antibodies
|
WO2003020698A2
(en)
|
2001-09-06 |
2003-03-13 |
Prochon Biotech Ltd. |
Protein tyrosine kinase inhibitors
|
PE20030762A1
(es)
|
2001-12-18 |
2003-09-05 |
Schering Corp |
Compuestos heterociclicos como antagonistas nk1
|
US7466344B2
(en)
|
2002-06-07 |
2008-12-16 |
Scimeasure Analytical Systems, Inc. |
High-speed low noise CCD controller
|
ITMI20021620A1
(it)
|
2002-07-23 |
2004-01-23 |
Novuspharma Spa |
Composto ad ativita' antitumorale
|
CA2493000A1
(en)
|
2002-07-24 |
2004-01-29 |
University Of Cincinnati |
4-4(methylpiperazin-1-ylmethyl)-n-[4-methyl-3-(pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide for treating mutated-ret kinase associated diseases
|
EP1597251B1
(en)
|
2003-02-20 |
2009-06-10 |
SmithKline Beecham Corporation |
Pyrimidine compounds
|
US20090143399A1
(en)
|
2003-10-14 |
2009-06-04 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Protein Kinase Inhibitors
|
CA2543116A1
(en)
|
2003-10-27 |
2005-05-19 |
Genelabs Technologies, Inc. |
Methods for preparing 7-(2'-substituted-.szlig.-d-ribofuranosyl)-4-(nr2r3)-5-(substituted ethyn-1-yl)-pyrrolo[2,3-d]pyrimidine derivatives
|
MY141220A
(en)
|
2003-11-17 |
2010-03-31 |
Astrazeneca Ab |
Pyrazole derivatives as inhibitors of receptor tyrosine kinases
|
PL1687305T3
(pl)
|
2003-11-21 |
2008-12-31 |
Novartis Ag |
Pochodne 1H-imidazochinolin jako inhibitory kinaz białkowych
|
TW200529849A
(en)
|
2003-11-28 |
2005-09-16 |
Novartis Ag |
Diaryl urea derivatives in the treatment of protein kinase dependent diseases
|
EP1696920B8
(en)
|
2003-12-19 |
2015-05-06 |
Plexxikon Inc. |
Compounds and methods for development of ret modulators
|
GB0330042D0
(en)
|
2003-12-24 |
2004-01-28 |
Pharmacia Italia Spa |
Pyrrolo [2,3-b] pyridine derivatives active as kinase inhibitors process for their preparation and pharmaceutical compositions them
|
GB0330043D0
(en)
|
2003-12-24 |
2004-01-28 |
Pharmacia Italia Spa |
Pyrrolo [2,3-b] pyridine derivatives active as kinase inhibitors process for their preparation and pharmaceutical compositions comprising them
|
WO2005068424A1
(en)
|
2004-01-20 |
2005-07-28 |
Cell Therapeutics Europe S.R.L. |
Indolinone derivatives as receptor tyrosine kinase ihibitors
|
AR049769A1
(es)
|
2004-01-22 |
2006-09-06 |
Novartis Ag |
Derivados de pirazolo(1,5-a)pirimidin 7-il-amina para utilizarse en el tratamiento de enfermedades dependientes de la quinasa de proteina
|
US20050222171A1
(en)
|
2004-01-22 |
2005-10-06 |
Guido Bold |
Organic compounds
|
WO2005099363A2
(en)
|
2004-03-26 |
2005-10-27 |
Whitehead Institute For Biomedical Research |
Methods of diagnosing, preventing and treating cancer metastasis
|
GB0512324D0
(en)
|
2005-06-16 |
2005-07-27 |
Novartis Ag |
Organic compounds
|
TW200615268A
(en)
|
2004-08-02 |
2006-05-16 |
Osi Pharm Inc |
Aryl-amino substituted pyrrolopyrimidine multi-kinase inhibiting compounds
|
PE20060664A1
(es)
|
2004-09-15 |
2006-08-04 |
Novartis Ag |
Amidas biciclicas como inhibidores de cinasa
|
US7855205B2
(en)
|
2004-10-29 |
2010-12-21 |
Janssen Pharmaceutica Nv |
Pyrimidinyl substituted fused-pyrrolyl compounds useful in treating kinase disorders
|
SI2213652T1
(sl)
|
2004-12-17 |
2015-03-31 |
The Trustees Of The University Of Pennsylvania |
Derivati stilbena in njihova uporaba za vezavo in prikaz amiloidnih plakov
|
DE102005003687A1
(de)
|
2005-01-26 |
2006-07-27 |
Sphingo Tec Gmbh |
Immunoassay zur Bestimmung der Freisetzung von Neurotensin in die Zirkulation
|
GB0501999D0
(en)
|
2005-02-01 |
2005-03-09 |
Sentinel Oncology Ltd |
Pharmaceutical compounds
|
WO2006089298A2
(en)
|
2005-02-18 |
2006-08-24 |
Attenuon, Llc |
Pyrimidine-fused diazepine derivatives and indole-fused pteridines
|
GB0507575D0
(en)
|
2005-04-14 |
2005-05-18 |
Novartis Ag |
Organic compounds
|
US7402579B2
(en)
|
2005-04-15 |
2008-07-22 |
Cylene Pharmaceuticals, Inc. |
Quinobenzoxazine analogs and compositions
|
EP1899323A2
(en)
|
2005-05-16 |
2008-03-19 |
AstraZeneca AB |
Pyrazolylaminopyrimidine derivatives useful as tyrosine kinase inhibitors
|
US20100047777A1
(en)
|
2005-05-26 |
2010-02-25 |
The Johns Hopkins University |
Methods for identifying mutations in coding and non-coding dna
|
EP1896462A2
(en)
|
2005-05-31 |
2008-03-12 |
The Pfahl Family Trust (Dated 9 July 1996) |
Substituted biarylheterocycle derivatives as protein kinase inhibitors for the treatment of cancer and other diseases
|
WO2006130673A1
(en)
|
2005-05-31 |
2006-12-07 |
Janssen Pharmaceutica, N.V. |
3-benzoimidazolyl-pyrazolopyridines useful in treating kinase disorders
|
ITRM20050290A1
(it)
|
2005-06-07 |
2006-12-08 |
Lay Line Genomics Spa |
Uso di molecole in grado di inibire il legame tra ngf e il suo recettore trka come analgesici ad effetto prolungato.
|
EP3088400A1
(en)
|
2005-06-22 |
2016-11-02 |
Plexxikon Inc. |
Pyrrolo[2,3-b]pyridine derivatives as protein kinase inhibitors
|
GB0515026D0
(en)
|
2005-07-21 |
2005-08-31 |
Novartis Ag |
Organic compounds
|
SI1919979T2
(sl)
|
2005-08-25 |
2017-07-31 |
Creabilis Therapeutics S.P.A. |
Polimerni konjugati K-252A in njihovi derivati
|
WO2007053776A1
(en)
|
2005-11-03 |
2007-05-10 |
Sgx Pharmaceuticals, Inc. |
Pyrimidinyl-thiophene kinase modulators
|
EP1785420A1
(en)
|
2005-11-14 |
2007-05-16 |
4Sc Ag |
Thiazole analogues and uses thereof
|
US20070149523A1
(en)
|
2005-11-14 |
2007-06-28 |
Jan Ehlert |
Thiazole Analogues and Uses Thereof
|
WO2007057399A2
(en)
|
2005-11-15 |
2007-05-24 |
Boehringer Ingelheim International Gmbh |
Treatment of cancer with indole derivatives
|
WO2007057397A1
(en)
|
2005-11-15 |
2007-05-24 |
Boehringer Ingelheim International Gmbh |
Treatment of cancer
|
GB0524436D0
(en)
|
2005-11-30 |
2006-01-11 |
Novartis Ag |
Organic compounds
|
WO2007065664A2
(en)
|
2005-12-08 |
2007-06-14 |
Novartis Ag |
Pyrazolo[1,5-a]pyridine-3-carboxylic acids as ephb and vegfr2 kinase inhibitors
|
EP1968579A1
(en)
|
2005-12-30 |
2008-09-17 |
Astex Therapeutics Limited |
Pharmaceutical compounds
|
EP1978958A4
(en)
|
2006-01-24 |
2009-12-02 |
Merck & Co Inc |
INHIBITION OF TYROSINE KINASE RET
|
CA2636701C
(en)
|
2006-01-27 |
2014-08-05 |
Shanghai Hengrui Pharmaceutical Co. Ltd. |
Pyrrolo [3,2-c] pyridine-4-one 2-indolinone protein kinase inhibitors
|
AU2007227602A1
(en)
|
2006-03-16 |
2007-09-27 |
Novartis Ag |
Heterocyclic organic compounds for the treatment of in particular melanoma
|
PT2001892E
(pt)
|
2006-03-17 |
2013-07-04 |
Ambit Biosciences Corp |
Compostos de imidazolotiazole para o tratamento de doenças proliferativas
|
US8263604B2
(en)
|
2006-03-27 |
2012-09-11 |
Nerviano Medical Sciences S.R.L. |
Pyridyl- and pyrimidinyl-substituted pyrrole-, thiophene- and furane-derivatives as kinase inhibitors
|
RU2008149245A
(ru)
|
2006-05-15 |
2010-06-20 |
Айрм Ллк (Bm) |
Композиции и способы ингибирования рецепторных киназ fgf
|
CN101443009A
(zh)
|
2006-05-18 |
2009-05-27 |
卫材R&D管理有限公司 |
针对甲状腺癌的抗肿瘤剂
|
US8063225B2
(en)
|
2006-08-14 |
2011-11-22 |
Chembridge Corporation |
Tricyclic compound derivatives useful in the treatment of neoplastic diseases, inflammatory disorders and immunomodulatory disorders
|
WO2008031551A2
(en)
|
2006-09-12 |
2008-03-20 |
Novartis Forschungsstiftung, Zweigniederlassung |
Non-neuroendocrine cancer therapy
|
ES2565683T3
(es)
|
2006-09-15 |
2016-04-06 |
Xcovery, Inc. |
Compuestos inhibidores de quinasa
|
US20120225057A1
(en)
|
2006-10-11 |
2012-09-06 |
Deciphera Pharmaceuticals, Llc |
Methods and compositions for the treatment of myeloproliferative diseases and other proliferative diseases
|
EP1918291A1
(en)
|
2006-10-30 |
2008-05-07 |
Novartis AG |
3-Aminocarbonyl-substituted fused pyrazolo-derivatives as protein kinase modulators
|
HUE035868T2
(en)
|
2006-11-15 |
2018-05-28 |
Ym Biosciences Australia Pty |
Inhibitors of kinase activity
|
WO2008071456A2
(en)
*
|
2006-12-15 |
2008-06-19 |
Bayer Schering Pharma Aktiengesellschaft |
3-h-pyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
|
WO2008079909A1
(en)
|
2006-12-21 |
2008-07-03 |
Plexxikon, Inc. |
Pyrrolo [2,3-b] pyridines as kinase modulators
|
PE20121126A1
(es)
|
2006-12-21 |
2012-08-24 |
Plexxikon Inc |
Compuestos pirrolo [2,3-b] piridinas como moduladores de quinasa
|
MX2009006688A
(es)
|
2006-12-21 |
2009-06-30 |
Plexxikon Inc |
Compuestos y metodos para modulacion de cinasas, e indicaciones para ello.
|
US20080199426A1
(en)
|
2007-01-11 |
2008-08-21 |
Sukhatme Vikas P |
Methods and compositions for the treatment and diagnosis of vascular inflammatory disorders or endothelial cell disorders
|
US20100173954A1
(en)
|
2007-01-19 |
2010-07-08 |
Bayer Healthcare Llc |
Treatment of cancers having resistance to chemotherapeutic agents
|
US20080234267A1
(en)
|
2007-03-20 |
2008-09-25 |
Karen Elizabeth Lackey |
Compounds and Methods of Treatment
|
US20110189167A1
(en)
|
2007-04-20 |
2011-08-04 |
Flynn Daniel L |
Methods and Compositions for the Treatment of Myeloproliferative Diseases and other Proliferative Diseases
|
EA019524B1
(ru)
|
2007-05-04 |
2014-04-30 |
Айрм Ллк |
СОЕДИНЕНИЯ И КОМПОЗИЦИИ КАК ИНГИБИТОРЫ КИНАЗЫ с-kit И PDGFR
|
WO2008138184A1
(fr)
|
2007-05-14 |
2008-11-20 |
Shanghai Hengrui Pharmaceutical Co.Ltd. |
Dérivés de pyrrolo-azacycles, leur procédé de fabrication et leur utilisation en tant qu'inhibiteurs de protéine kinases
|
US20090012045A1
(en)
|
2007-06-26 |
2009-01-08 |
Rigel Pharmaceuticals, Inc. |
Methods of Treating Cell Proliferative Disorders
|
AU2008273889B2
(en)
|
2007-07-09 |
2012-03-08 |
Astrazeneca Ab |
Trisubstituted pyrimidine derivatives for the treatment of proliferative diseases
|
WO2009012262A1
(en)
|
2007-07-16 |
2009-01-22 |
The Regents Of The University Of California |
Protein kinase modulating compounds and methods for making and using them
|
NZ582772A
(en)
|
2007-07-17 |
2012-06-29 |
Plexxikon Inc |
Compounds and methods for kinase modulation, and indications therefor
|
AR067585A1
(es)
|
2007-07-19 |
2009-10-14 |
Schering Corp |
Compuestos heterociclicos de amidas como inhibidores de la proteincinasa
|
WO2009013126A1
(en)
|
2007-07-20 |
2009-01-29 |
Nerviano Medical Sciences S.R.L. |
Substituted indazole derivatives active as kinase inhibitors
|
WO2009017838A2
(en)
|
2007-08-01 |
2009-02-05 |
Exelixis, Inc. |
Combinations of jak-2 inhibitors and other agents
|
WO2009021137A2
(en)
|
2007-08-07 |
2009-02-12 |
Purdue Research Foundation |
Kinase inhibitors and uses thereof
|
EP2025678A1
(en)
|
2007-08-17 |
2009-02-18 |
Oncalis AG |
Pyrazolo[3,4-d]pyrimidine compounds and their use as modulators of protein kinase
|
WO2009042646A1
(en)
|
2007-09-24 |
2009-04-02 |
Curis, Inc. |
Anti-proliferative agents
|
CN101909647A
(zh)
|
2007-10-23 |
2010-12-08 |
诺瓦提斯公司 |
TrkB抗体用于治疗呼吸病症的用途
|
EP2215091B1
(en)
|
2007-12-04 |
2016-03-30 |
Nerviano Medical Sciences S.r.l. |
Substituted dihydropteridin-6-one derivatives, process for their preparation and their use as kinase inhibitors
|
CN101459004B
(zh)
|
2007-12-14 |
2011-02-09 |
深圳富泰宏精密工业有限公司 |
电子装置的按键面板结构及制造该按键面板结构的方法
|
WO2009092049A1
(en)
|
2008-01-17 |
2009-07-23 |
Irm Llc |
Improved anti-trkb antibodies
|
US20090227556A1
(en)
|
2008-01-31 |
2009-09-10 |
Eisai R&D Management Co., Ltd. |
Receptor tyrosine kinase inhibitors comprising pyridine and pyrimidine derivatives
|
TW200942537A
(en)
|
2008-02-01 |
2009-10-16 |
Irm Llc |
Compounds and compositions as kinase inhibitors
|
US20090209496A1
(en)
|
2008-02-15 |
2009-08-20 |
David Chaplin |
Methods and compositions for enhancing the efficacy of rtk inhibitors
|
US8822500B2
(en)
|
2008-03-19 |
2014-09-02 |
Chembridge Corporation |
Tyrosine kinase inhibitors
|
JP5628145B2
(ja)
|
2008-03-19 |
2014-11-19 |
ケムブリッジ・コーポレーション |
新規チロシンキナーゼ阻害剤
|
US8207165B2
(en)
|
2008-03-28 |
2012-06-26 |
Nerviano Medical Sciences S.R.L. |
3,4-dihydro-2H-pyrazino[1,2-A]indol-1-one derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
|
US8158636B2
(en)
|
2008-05-19 |
2012-04-17 |
Plexxikon Inc. |
Compounds and methods for kinase modulation, and indications therefor
|
PE20091846A1
(es)
|
2008-05-19 |
2009-12-16 |
Plexxikon Inc |
DERIVADOS DE PIRROLO[2,3-d]-PIRIMIDINA COMO MODULADORES DE CINASAS
|
JP5351254B2
(ja)
|
2008-05-23 |
2013-11-27 |
ノバルティス アーゲー |
キノキサリン−およびキノリン−カルボキシアミド誘導体
|
EP2313411A1
(en)
|
2008-06-10 |
2011-04-27 |
Plexxikon, Inc. |
5h-pyrr0l0 [2,3-b]pyrazine derivatives for kinase modulation, and indications therefor
|
US20110212053A1
(en)
|
2008-06-19 |
2011-09-01 |
Dapeng Qian |
Phosphatidylinositol 3 kinase inhibitors
|
EP2313091A4
(en)
|
2008-07-14 |
2012-04-04 |
Univ Kingston |
PHARMACEUTICAL COMPOSITIONS WITH RET-HEMMERN AND METHOD FOR THE TREATMENT OF CANCER
|
JO3041B1
(ar)
*
|
2008-07-25 |
2016-09-05 |
Galapagos Nv |
مركبات جديدة مفيدة لمعالجة الأمراض التنكسية والالتهابية
|
ES2532732T3
(es)
|
2008-07-29 |
2015-03-31 |
Nerviano Medical Sciences S.R.L. |
Uso de un inhibidor de CDK para el tratamiento del glioma
|
KR101246656B1
(ko)
|
2008-09-01 |
2013-03-25 |
샤프 가부시키가이샤 |
유기 일렉트로루미네센스 패널, 유기 일렉트로루미네센스 디스플레이, 유기 일렉트로루미네센스 조명 및 그들의 제조 방법
|
WO2010028254A2
(en)
|
2008-09-05 |
2010-03-11 |
Auspek Pharmaceuticals, Inc. |
Substituted quinazoline inhibitors of growth factor receptor tyrosine kinases
|
EP2161271A1
(en)
|
2008-09-08 |
2010-03-10 |
Università Degli Studi Di Milano - Bicocca |
Alpha-carboline inhibitors of NMP-ALK, RET, and Bcr-Abl
|
ES2536730T3
(es)
|
2008-09-19 |
2015-05-28 |
Nerviano Medical Sciences S.R.L. |
Derivados de 3,4-dihidro-2H-pirrolo[1,2-a]pirazin-1-ona
|
WO2010033941A1
(en)
|
2008-09-22 |
2010-03-25 |
Array Biopharma Inc. |
Substituted imidazo[1,2b]pyridazine compounds as trk kinase inhibitors
|
KR101718386B1
(ko)
|
2008-09-26 |
2017-03-21 |
내셔날 헬스 리서치 인스티튜트 |
단백질 키나아제 억제제로서의 융합 다환 화합물
|
UY32192A
(es)
|
2008-10-22 |
2011-05-31 |
Array Biopharma Inc |
COMPUESTOS PIRAZOLO[1,5-a]PIRIMIDINA SUSTITUIDA COMO INHIBIDORES DE TRK CINASA
|
EP2358725A1
(en)
|
2008-11-06 |
2011-08-24 |
Ambit Biosciences Corporation |
Imidazolothiazole compounds as modulators of protein kinase
|
EP2376084B1
(en)
|
2008-11-24 |
2013-07-17 |
Nerviano Medical Sciences S.r.l. |
CDK inhibitor for the treatment of mesothelioma
|
KR101061599B1
(ko)
|
2008-12-05 |
2011-09-02 |
한국과학기술연구원 |
비정상 세포 성장 질환의 치료를 위한 단백질 키나아제 저해제인 신규 인다졸 유도체, 이의 약학적으로 허용가능한염 및 이를 유효성분으로 함유하는 약학적 조성물
|
JO3265B1
(ar)
|
2008-12-09 |
2018-09-16 |
Novartis Ag |
مثبطات بيريديلوكسى اندولات vegf-r2 واستخدامها لعلاج المرض
|
AU2010224523B2
(en)
*
|
2009-03-18 |
2014-05-08 |
Resverlogix Corp. |
Novel anti-inflammatory agents
|
WO2010111527A1
(en)
|
2009-03-26 |
2010-09-30 |
Plexxikon, Inc. |
Pyrazolo [ 3, 4 -b] pyridines as kinase inhibitors and their medical use
|
US8492374B2
(en)
|
2009-04-29 |
2013-07-23 |
Industrial Technology Research Institute |
Azaazulene compounds
|
MX2011011875A
(es)
|
2009-05-08 |
2011-12-08 |
Astellas Pharma Inc |
Compuesto de carboxamida heterociclica diamino.
|
JP6073677B2
(ja)
|
2009-06-12 |
2017-02-01 |
デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド |
縮合複素環式化合物およびそれらの使用
|
JP5789602B2
(ja)
|
2009-06-15 |
2015-10-07 |
ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ |
置換ピリミジニルピロロピリジノン誘導体、これらの製造のための方法およびキナーゼ阻害剤としてのこれらの使用
|
AR077468A1
(es)
|
2009-07-09 |
2011-08-31 |
Array Biopharma Inc |
Compuestos de pirazolo (1,5 -a) pirimidina sustituidos como inhibidores de trk- quinasa
|
PT2467141T
(pt)
|
2009-08-17 |
2019-02-06 |
Intellikine Llc |
Compostos heterocíclicos e suas utilizações
|
KR101256018B1
(ko)
|
2009-08-20 |
2013-04-18 |
한국과학기술연구원 |
단백질 키나아제 저해활성을 갖는 1,3,6-치환된 인돌 화합물
|
FR2951172B1
(fr)
|
2009-10-13 |
2014-09-26 |
Pf Medicament |
Derives pyrazolopyridines en tant qu'agent anticancereux
|
KR101147550B1
(ko)
|
2009-10-22 |
2012-05-17 |
한국과학기술연구원 |
단백질 키나아제 저해활성을 가지는 2,7-치환된 티에노[3,2-d]피리미딘 화합물
|
KR101116756B1
(ko)
|
2009-10-27 |
2012-03-13 |
한국과학기술연구원 |
단백질 키나아제 저해활성을 갖는 신규의 1,6-치환된 인돌 화합물
|
US8404677B2
(en)
|
2009-10-29 |
2013-03-26 |
Genosco |
Kinase inhibitors
|
CA2780892C
(en)
|
2009-11-13 |
2017-02-14 |
Genosco |
Kinase inhibitors
|
KR101094446B1
(ko)
|
2009-11-19 |
2011-12-15 |
한국과학기술연구원 |
단백질 키나아제 저해활성을 가지는 2,4,7-치환된 티에노[3,2-d]피리미딘 화합물
|
CA2784807C
(en)
|
2009-12-29 |
2021-12-14 |
Dana-Farber Cancer Institute, Inc. |
Type ii raf kinase inhibitors
|
SG182361A1
(en)
|
2010-01-29 |
2012-08-30 |
Hanmi Science Co Ltd |
THIENO[3,2-d]PYRIMIDINE DERIVATIVES HAVING INHIBITORY ACTIVITY ON PROTEIN KINASES
|
KR101483215B1
(ko)
|
2010-01-29 |
2015-01-16 |
한미약품 주식회사 |
단백질 키나아제 저해활성을 갖는 비시클릭 헤테로아릴 유도체
|
WO2011092120A1
(en)
|
2010-01-29 |
2011-08-04 |
Nerviano Medical Sciences S.R.L. |
6,7- dihydroimidazo [1,5-a] pyrazin-8 (5h) - one derivatives as protein kinase modulators
|
WO2011101408A1
(en)
|
2010-02-18 |
2011-08-25 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Method for preventing cancer metastasis
|
TWI619713B
(zh)
|
2010-04-21 |
2018-04-01 |
普雷辛肯公司 |
用於激酶調節的化合物和方法及其適應症
|
HUE035337T2
(en)
|
2010-05-20 |
2018-05-02 |
Array Biopharma Inc |
Macrocyclic compounds as TRK kinase inhibitors
|
UY33597A
(es)
|
2010-09-09 |
2012-04-30 |
Irm Llc |
Compuestos y composiciones como inhibidores de la trk
|
WO2012034095A1
(en)
|
2010-09-09 |
2012-03-15 |
Irm Llc |
Compounds and compositions as trk inhibitors
|
WO2012047017A2
(ko)
|
2010-10-05 |
2012-04-12 |
크리스탈지노믹스(주) |
2,3-디히드로-이소인돌-1-온 유도체 및 이를 포함하는 조성물
|
JP2014005206A
(ja)
|
2010-10-22 |
2014-01-16 |
Astellas Pharma Inc |
アリールアミノヘテロ環カルボキサミド化合物
|
BR112013018515B1
(pt)
|
2011-01-26 |
2021-06-29 |
Nerviano Medical Sciences S.R.I |
Derivados de pirrol tricíclico, processo para sua preparação e seu uso como inibidores da quinase
|
EP2668188B1
(en)
|
2011-01-26 |
2016-05-18 |
Nerviano Medical Sciences S.r.l. |
Tricyclic derivatives, process for their preparation and their use as kinase inhibitors
|
CN102093421B
(zh)
|
2011-01-28 |
2014-07-02 |
北京康辰药业有限公司 |
一种含磷取代基的喹啉类化合物及其制备方法、以及含有该化合物的药物组合物及其应用
|
PT2672967T
(pt)
|
2011-02-07 |
2018-12-07 |
Plexxikon Inc |
Compostos e métodos de modulação da quinase e suas indicações
|
CN103403002B
(zh)
|
2011-02-24 |
2016-06-22 |
内尔维阿诺医学科学有限公司 |
作为激酶抑制剂的噻唑基苯基-苯磺酰氨基衍生物
|
PE20140378A1
(es)
|
2011-02-25 |
2014-03-28 |
Irm Llc |
Compuestos y composiciones como inhibidores de la trk
|
US8791112B2
(en)
|
2011-03-30 |
2014-07-29 |
Arrien Pharmaceuticals Llc |
Substituted 5-(pyrazin-2-yl)-1H-pyrazolo [3, 4-B] pyridine and pyrazolo [3, 4-B] pyridine derivatives as protein kinase inhibitors
|
BR112013025387B1
(pt)
|
2011-04-01 |
2021-07-27 |
University Of Utah Research Foundation |
Compostos análogos substituídos da n-fenilpirimidin-2-amina como inibidores da quinase axl, uso dos ditos compostos para o tratamento de um distúrbio de proliferação celular descontrolada, bem como kit compreendendo ditos compostos
|
EP2702055A1
(en)
|
2011-04-11 |
2014-03-05 |
Nerviano Medical Sciences S.r.l. |
Pyrazolyl-pyrimidine derivatives as kinase inhibitors
|
RU2621732C2
(ru)
|
2011-04-19 |
2017-06-07 |
НЕРВИАНО МЕДИКАЛ САЙЕНСИЗ С.р.л. |
Замещенные пиримидинилпирролы, активные в качестве ингибиторов киназы
|
AR086042A1
(es)
*
|
2011-04-28 |
2013-11-13 |
Galapagos Nv |
Compuesto util para el tratamiento de enfermedades degenerativas e inflamatorias y composicion farmaceutica
|
ES2611779T3
(es)
|
2011-05-12 |
2017-05-10 |
Nerviano Medical Sciences S.R.L. |
Derivados de indazol sustituidos activos como inhibidores de quinasas
|
LT2712358T
(lt)
|
2011-05-13 |
2017-01-25 |
Array Biopharma, Inc. |
Pirolidinilkarbamido, pirolidiniltiokarbamido ir pirolidinilguanidino junginiai kaip trka kinazės inhibitoriai
|
RU2477723C2
(ru)
|
2011-06-16 |
2013-03-20 |
Общество С Ограниченной Ответственностью "Фьюжн Фарма" |
Ингибиторы протеинкиназ (варианты), их применение для лечения онкологических заболеваний и фармацевтическая композиция на их основе
|
CN102827073A
(zh)
*
|
2011-06-17 |
2012-12-19 |
安吉奥斯医药品有限公司 |
治疗活性组合物和它们的使用方法
|
WO2013016720A2
(en)
|
2011-07-28 |
2013-01-31 |
Gerinda Therapeutics, Inc. |
Novel substituted biarylheterocycle derivatives as protein kinase inhibitors for the treatment of cancer and other diseases
|
EP2736514B1
(en)
|
2011-07-28 |
2017-10-18 |
Nerviano Medical Sciences S.r.l. |
Alkynyl substituted pyrimidinyl-pyrroles active as kinases inhibitors
|
CA2848369A1
(en)
|
2011-08-04 |
2013-02-07 |
National Cancer Center |
Fusion gene of kif5b gene and ret gene, and method for determining effectiveness of cancer treatment targeting fusion gene
|
EP2748192B2
(en)
|
2011-08-23 |
2022-04-20 |
Foundation Medicine, Inc. |
Kif5b-ret fusion molecules and uses thereof
|
AU2012341028C1
(en)
|
2011-09-02 |
2017-10-19 |
Mount Sinai School Of Medicine |
Substituted pyrazolo[3,4-D]pyrimidines and uses thereof
|
WO2013036232A2
(en)
|
2011-09-08 |
2013-03-14 |
Deciphera Pharmaceuticals, Llc |
Methods and compositions for the treatment of myeloproliferative diseases and other proliferative diseases
|
WO2013042137A1
(en)
|
2011-09-19 |
2013-03-28 |
Aurigene Discovery Technologies Limited |
Bicyclic heterocycles as irak4 inhibitors
|
CN102408411B
(zh)
|
2011-09-19 |
2014-10-22 |
北京康辰药业股份有限公司 |
一种含喹啉基的羟肟酸类化合物及其制备方法、以及含有该化合物的药物组合物及其应用
|
JP5998223B2
(ja)
|
2011-10-07 |
2016-09-28 |
ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ |
キナーゼ阻害剤としての置換3,4−ジヒドロピロロ[1,2−a]ピラジン−1(2H)−オン誘導体
|
WO2013050448A1
(en)
|
2011-10-07 |
2013-04-11 |
Nerviano Medical Sciences S.R.L. |
4-ALKYL SUBSTITUTED 3,4-DIHYDROPYRROLO[1,2-a]PYRAZIN-1(2H)-ONE DERIVATIVES AS KINASES INHIBITORS
|
JP2014533286A
(ja)
|
2011-11-14 |
2014-12-11 |
テサロ, インコーポレイテッド |
特定のチロシンキナーゼの調節
|
JPWO2013081188A1
(ja)
|
2011-11-30 |
2015-04-27 |
独立行政法人国立がん研究センター |
誘導悪性幹細胞
|
PE20141404A1
(es)
|
2011-12-30 |
2014-10-28 |
Hanmi Pharm Ind Co Ltd |
Derivados de tieno[3,2-d]pirimidina que tienen actividad inhibidora por las quinasas de las proteinas
|
US8377946B1
(en)
|
2011-12-30 |
2013-02-19 |
Pharmacyclics, Inc. |
Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors
|
JP2015109806A
(ja)
|
2012-03-22 |
2015-06-18 |
アステラス製薬株式会社 |
新規ret融合体の検出法
|
TW201350479A
(zh)
|
2012-04-26 |
2013-12-16 |
Ono Pharmaceutical Co |
Trk阻害化合物
|
EP2849751A1
(en)
|
2012-05-10 |
2015-03-25 |
Synta Pharmaceuticals Corp. |
Treating cancer with hsp90 inhibitory compounds
|
CN104395308B
(zh)
|
2012-05-23 |
2016-08-24 |
内尔维阿诺医学科学有限公司 |
N-[5-(3,5-二氟-苄基)-1h-吲唑-3-基]-4-(4-甲基-哌嗪-1-基)-2-(四氢-吡喃-4-基氨基)-苯甲酰胺的制备方法
|
TWI585088B
(zh)
|
2012-06-04 |
2017-06-01 |
第一三共股份有限公司 |
作爲激酶抑制劑之咪唑并[1,2-b]嗒衍生物
|
RS62233B1
(sr)
|
2012-07-11 |
2021-09-30 |
Blueprint Medicines Corp |
Inhibitori receptora fibroblast faktora rasta
|
WO2014011187A1
(en)
|
2012-07-13 |
2014-01-16 |
Otis Elevator Company |
Belt including fibers
|
JPWO2014017491A1
(ja)
|
2012-07-26 |
2016-07-11 |
国立研究開発法人国立がん研究センター |
Cep55遺伝子とret遺伝子との融合遺伝子
|
US9688661B2
(en)
|
2012-08-02 |
2017-06-27 |
Nerviano Medical Sciences S.R.L. |
Substituted pyrroles active as kinases inhibitors
|
JP6513567B2
(ja)
|
2012-09-07 |
2019-05-15 |
エクセリクシス, インク. |
肺腺癌の治療で使用するためのmet、vegfr、およびretの阻害剤
|
CA3077553C
(en)
|
2012-09-25 |
2022-08-02 |
Chugai Seiyaku Kabushiki Kaisha |
Ret inhibitor
|
ES2755772T3
(es)
|
2012-11-07 |
2020-04-23 |
Nerviano Medical Sciences Srl |
Pirimidinil y piridinilpirrolopiridinonas sustituidas, proceso para su preparación y su uso como inhibidores de cinasas
|
EA029706B1
(ru)
|
2012-11-12 |
2018-05-31 |
Игнайта, Инк. |
Сложные алкиловые эфиры бендамустина и способы их применения
|
US9969694B2
(en)
|
2012-11-13 |
2018-05-15 |
Array Biopharma Inc. |
N-(arylalkyl)-N′-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
|
US9809578B2
(en)
|
2012-11-13 |
2017-11-07 |
Array Biopharma Inc. |
Pyrazolyl urea, thiourea, guanidine and cyanoguanidine compounds as trkA kinase inhibitors
|
WO2014078408A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
Bicyclic heteroaryl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
DK2920166T3
(en)
|
2012-11-13 |
2017-02-06 |
Array Biopharma Inc |
SUITABLE BICYCLIC UREA, THIOUREA, GUANIDINE AND CYANOGUANIDE COMPOUNDS FOR PAIN TREATMENT
|
US9828360B2
(en)
|
2012-11-13 |
2017-11-28 |
Array Biopharma Inc. |
Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
|
WO2014078325A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
N-(monocyclic aryl),n'-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
NZ708028A
(en)
|
2012-11-13 |
2018-12-21 |
Array Biopharma Inc |
N-pyrrolidinyl, n’-pyrazolyl- urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
WO2014078328A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
N-bicyclic aryl,n'-pyrazolyl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
WO2014078322A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
Thiazolyl and oxazolyl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
WO2014078372A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
EP2925359A2
(en)
|
2012-11-29 |
2015-10-07 |
Yeda Research and Development Co., Ltd. |
Methods of preventing tumor metastasis, treating and prognosing cancer and identifying agents which are putative metastasis inhibitors
|
WO2014086284A1
(zh)
|
2012-12-04 |
2014-06-12 |
上海医药集团股份有限公司 |
一类氘代3-氰基喹啉类化合物、其药用组合物、制备方法及其用途
|
FR3000493A1
(fr)
|
2012-12-28 |
2014-07-04 |
Oribase Pharma |
Nouveaux inhibiteurs de proteines kinases
|
BR112015015477B1
(pt)
|
2012-12-28 |
2022-07-12 |
Crystalgenomics, Inc |
Derivados de 2,3-di-hidro-isoindol-1-ona e métodos de uso dos mesmos como inibidores de btk
|
FR3000494B1
(fr)
|
2012-12-28 |
2015-08-21 |
Oribase Pharma |
Nouveaux derives d'azaindoles en tant qu'inhibiteurs de proteines kinases
|
FR3000492B1
(fr)
|
2012-12-28 |
2015-09-11 |
Oribase Pharma |
Nouveaux derives azaindole en tant qu'inhibiteurs multikinases
|
MX346411B
(es)
|
2013-02-19 |
2017-03-17 |
Ono Pharmaceutical Co |
Compuesto inhibidor de cinasa del receptor de tropomiosina (trk).
|
US20160151461A1
(en)
|
2013-03-14 |
2016-06-02 |
The Trustees Of The University Of Pennsylvania |
Cardio-Metabolic and Vascular Effects of GLP-1 Metabolites
|
RS55710B1
(sr)
|
2013-03-15 |
2017-07-31 |
Glaxosmithkline Ip Dev Ltd |
Derivati piridina kao inhibitori kinaze rearanžirane tokom transfekcije (ret)
|
US9499522B2
(en)
|
2013-03-15 |
2016-11-22 |
Blueprint Medicines Corporation |
Compositions useful for treating disorders related to kit
|
US8937071B2
(en)
|
2013-03-15 |
2015-01-20 |
Glaxosmithkline Intellectual Property Development Limited |
Compounds as rearranged during transfection (RET) inhibitors
|
EP2997030B1
(en)
|
2013-05-14 |
2017-08-09 |
Nerviano Medical Sciences S.R.L. |
Pyrrolo[2,3-d]pyrimidine derivatives, process for their preparation and their use as kinase inhibitors
|
AU2014274093B2
(en)
|
2013-05-30 |
2018-11-08 |
Plexxikon Inc. |
Compounds for kinase modulation, and indications therefor
|
WO2015017528A1
(en)
|
2013-07-30 |
2015-02-05 |
Blueprint Medicines Corporation |
Pik3c2g fusions
|
WO2015017533A1
(en)
|
2013-07-30 |
2015-02-05 |
Blueprint Medicines Corporation |
Ntrk2 fusions
|
EP3037547A1
(en)
|
2013-08-20 |
2016-06-29 |
National Cancer Center |
New fusion gene detected in lung cancer
|
KR20160055170A
(ko)
|
2013-08-30 |
2016-05-17 |
암비트 바이오사이언시즈 코포레이션 |
바이아릴 아세트아미드 화합물 및 이의 사용 방법
|
BR112016006444B1
(pt)
*
|
2013-09-30 |
2021-01-19 |
Korea Research Institute Of Chemical Technology |
derivado de triazolopirazina e composições farmacêuticas compreendendo o mesmo
|
EP3057969B1
(en)
|
2013-10-17 |
2018-06-13 |
Blueprint Medicines Corporation |
Compositions useful for treating disorders related to kit
|
US9334263B2
(en)
|
2013-10-17 |
2016-05-10 |
Blueprint Medicines Corporation |
Compositions useful for treating disorders related to kit
|
CA2928042C
(en)
|
2013-10-25 |
2022-05-10 |
Blueprint Medicines Corporation |
Inhibitors of the fibroblast growth factor receptor
|
GB201321146D0
(en)
|
2013-11-29 |
2014-01-15 |
Cancer Rec Tech Ltd |
Quinazoline compounds
|
EP3076966A2
(en)
|
2013-12-02 |
2016-10-12 |
BerGenBio AS |
Use of kinase inhibitors
|
US9695165B2
(en)
|
2014-01-15 |
2017-07-04 |
Blueprint Medicines Corporation |
Inhibitors of the fibroblast growth factor receptor
|
ES2933350T3
(es)
|
2014-01-24 |
2023-02-06 |
Turning Point Therapeutics Inc |
Macrociclos de diarilo como moduladores de proteína quinasas
|
US10501418B2
(en)
|
2014-02-14 |
2019-12-10 |
Exelixis, Inc. |
Crystalline solid forms of N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N′-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, processes for making, and methods of use
|
US10231965B2
(en)
|
2014-02-20 |
2019-03-19 |
Ignyta, Inc. |
Molecules for administration to ROS1 mutant cancer cells
|
US20170044622A1
(en)
|
2014-04-18 |
2017-02-16 |
Blueprint Medicines Corporation |
Pik3ca fusions
|
EP3132054B1
(en)
|
2014-04-18 |
2021-06-30 |
Blueprint Medicines Corporation |
Met fusions
|
ES2746530T3
(es)
|
2014-05-15 |
2020-03-06 |
Array Biopharma Inc |
1-((3S,4R)-4-(3-fluorofenil)-1-(2-metoxietil)pirrolidín-3-il)-3-(4-metil-3-(2-metilpirimidín-5-il)-1-fenil-1H-pirazol-5- il)urea como un inhibidor de TrkA cinasa
|
WO2015191666A2
(en)
|
2014-06-10 |
2015-12-17 |
Blueprint Medicines Corporation |
Raf1 fusions
|
WO2015191667A1
(en)
|
2014-06-10 |
2015-12-17 |
Blueprint Medicines Corporation |
Pkn1 fusions
|
US10065934B2
(en)
|
2014-07-17 |
2018-09-04 |
Sunshine Lake Pharma Co., Ltd. |
Substituted urea derivatives and pharmaceutical uses thereof
|
WO2016011144A1
(en)
|
2014-07-17 |
2016-01-21 |
Blueprint Medicines Corporation |
Tert fusions
|
EP3169804B3
(en)
|
2014-07-17 |
2019-09-18 |
Blueprint Medicines Corporation |
Fgr fusions
|
WO2016011147A1
(en)
|
2014-07-17 |
2016-01-21 |
Blueprint Medicines Corporation |
Prkc fusions
|
WO2016022569A1
(en)
|
2014-08-04 |
2016-02-11 |
Blueprint Medicines Corporation |
Compositions useful for treating disorders related to kit
|
HUE045237T2
(hu)
|
2014-08-18 |
2019-12-30 |
Ono Pharmaceutical Co |
TRK-inhibitáló vegyület savaddíciós sója
|
KR20170047396A
(ko)
|
2014-09-08 |
2017-05-04 |
글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 |
2-(4-(4-에톡시-6-옥소-1,6-디히드로피리딘-3-일)-2-플루오로페닐)-n-(5-(1,1,1-트리플루오로-2-메틸프로판-2-일)이속사졸-3-일)아세트아미드의 결정질 형태
|
CR20170094A
(es)
|
2014-09-10 |
2017-05-08 |
Glaxosmithkline Ip Dev Ltd |
Nuevos compuestos como inhibidores de reorganizado durante la transfección (ret)
|
HUE044604T2
(hu)
|
2014-09-10 |
2019-11-28 |
Glaxosmithkline Ip Dev Ltd |
Piridin-származékok mint transzfekció alatt átrendezõdött (RET) kináz inhibitorok
|
TWI538914B
(zh)
|
2014-10-03 |
2016-06-21 |
國立交通大學 |
蛋白質激酶之選擇性抑制劑、其醫藥組成物及其用途
|
CA2967125C
(en)
|
2014-11-14 |
2022-10-25 |
Nerviano Medical Sciences S.R.L. |
6-amino-7-bicyclo-7-deaza-purine derivatives as protein kinase inhibitors
|
KR102649887B1
(ko)
|
2014-11-16 |
2024-03-22 |
어레이 바이오파마 인크. |
(s)-n-(5-((r)-2-(2,5-디플루오로페닐)-피롤리딘-1-일)-피라졸로[1,5-a]피리미딘-3-일)-3-히드록시피롤리딘-1-카르복스아미드 히드로겐 술페이트의 결정질 형태
|
EP3221700B1
(en)
|
2014-11-18 |
2022-06-22 |
Blueprint Medicines Corporation |
Prkacb fusions
|
WO2016096709A1
(en)
|
2014-12-16 |
2016-06-23 |
Eudendron S.R.L. |
Heterocyclic derivatives modulating activity of certain protein kinases
|
WO2016127074A1
(en)
|
2015-02-06 |
2016-08-11 |
Blueprint Medicines Corporation |
2-(pyridin-3-yl)-pyrimidine derivatives as ret inhibitors
|
KR101675984B1
(ko)
|
2015-02-23 |
2016-11-14 |
한양대학교 에리카산학협력단 |
티에노디아제핀 유도체 또는 이의 약학적으로 허용가능한 염, 및 이를 유효성분으로 포함하는 약학적 조성물
|
EP3265079A4
(en)
|
2015-03-03 |
2019-01-02 |
Caris MPI, Inc. |
Molecular profiling for cancer
|
CN108137593B
(zh)
|
2015-04-21 |
2021-01-05 |
上海交通大学医学院附属瑞金医院 |
蛋白激酶抑制剂的制备和用途
|
GB201512365D0
(en)
|
2015-07-15 |
2015-08-19 |
King S College London |
Novel therapy
|
TN2018000027A1
(en)
|
2015-07-16 |
2019-07-08 |
Array Biopharma Inc |
Substituted pyrazolo[1,5-a]pyridine compounds as ret kinase inhibitors
|
EP3120851A1
(en)
|
2015-07-21 |
2017-01-25 |
Pangaea Biotech S.L. |
4-amino-6-(2,6-dichlorophenyl)-8-methyl-2-(phenylamino)-pyrido[2,3-d]pyrimidin-7(8h)-one for treatment of solid cancers
|
KR101766194B1
(ko)
|
2015-08-07 |
2017-08-10 |
한국과학기술연구원 |
RET 키나아제 저해제인 신규 3-(이속사졸-3-일)-피라졸로[3,4-d]피리미딘-4-아민 화합물
|
WO2017027883A1
(en)
|
2015-08-13 |
2017-02-16 |
San Diego State University Research Foundation |
Atropisomerism for increased kinase inhibitor selectivity
|
MA41559A
(fr)
|
2015-09-08 |
2017-12-26 |
Taiho Pharmaceutical Co Ltd |
Composé de pyrimidine condensé ou un sel de celui-ci
|
WO2017049462A1
(zh)
|
2015-09-22 |
2017-03-30 |
合肥中科普瑞昇生物医药科技有限公司 |
一类新型的flt3激酶抑制剂及其用途
|
CN105255927B
(zh)
|
2015-09-30 |
2018-07-27 |
温州医科大学附属第一医院 |
一种kiaa1217-ret融合基因
|
TWI757256B
(zh)
|
2015-11-02 |
2022-03-11 |
美商纜圖藥品公司 |
轉染過程重排之抑制劑
|
US20190002988A1
(en)
|
2015-12-08 |
2019-01-03 |
Boehringer Ingelheim International Gmbh |
Method of using a ret fusion gene as a biomarker to select non small cell lung cancer (nsclc) and thyroid cancer patients for a cancer treatment
|
JP6871869B2
(ja)
|
2016-01-15 |
2021-05-19 |
公益財団法人がん研究会 |
新規融合体及びその検出法
|
TWI620748B
(zh)
|
2016-02-05 |
2018-04-11 |
National Health Research Institutes |
氨基噻唑化合物及其用途
|
EP3269370B1
(en)
|
2016-02-23 |
2020-01-08 |
Taiho Pharmaceutical Co., Ltd. |
Novel condensed pyrimidine compound or salt thereof
|
WO2017145050A1
(en)
|
2016-02-23 |
2017-08-31 |
Glaxosmithkline Intellectual Property Development Limited |
Pyridylpyridone derivative useful as a ret kinase inhibitor in the treatment of ibs and cancer
|
AR107912A1
(es)
|
2016-03-17 |
2018-06-28 |
Blueprint Medicines Corp |
Inhibidores de ret
|
US10045991B2
(en)
|
2016-04-04 |
2018-08-14 |
Loxo Oncology, Inc. |
Methods of treating pediatric cancers
|
RS63609B1
(sr)
|
2016-04-15 |
2022-10-31 |
Cancer Research Tech Ltd |
Heterociklična jedinjenja kao inhibitori ret kinaze
|
JP6943876B2
(ja)
|
2016-04-15 |
2021-10-06 |
キャンサー・リサーチ・テクノロジー・リミテッドCancer Research Technology Limited |
Retキナーゼ阻害剤としての複素環化合物
|
JOP20190077A1
(ar)
|
2016-10-10 |
2019-04-09 |
Array Biopharma Inc |
مركبات بيرازولو [1، 5-a]بيريدين بها استبدال كمثبطات كيناز ret
|
TWI704148B
(zh)
|
2016-10-10 |
2020-09-11 |
美商亞雷生物製藥股份有限公司 |
作為ret激酶抑制劑之經取代吡唑并[1,5-a]吡啶化合物
|